Healthcare provider profile · identity verified

Alejandro Fuentes, M.D.

Family Practice · WESLACO, TX · NPI 1619940475

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	449	149
Amlodipine Besylate	Amlodipine Besylate	432	143
Losartan Potassium	Losartan Potassium	345	110
Lisinopril	Lisinopril	295	104
Pravastatin Sodium	Pravastatin Sodium	254	74
Levothyroxine Sodium	Levothyroxine Sodium	237	75
Tamsulosin Hcl	Tamsulosin Hcl	226	83
Hydrochlorothiazide	Hydrochlorothiazide	221	72
Omeprazole	Omeprazole	219	80
Metoprolol Succinate	Metoprolol Succinate	214	77
Metformin Hcl Er	Metformin Hcl	200	63
Gabapentin	Gabapentin	185	65
Fluticasone Propionate	Fluticasone Propionate	182	84
Rosuvastatin Calcium	Rosuvastatin Calcium	169	57
Metformin Hcl	Metformin Hcl	164	58
Baclofen	Baclofen	162	80
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	154	34
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	145	53
Pantoprazole Sodium	Pantoprazole Sodium	142	48
Simvastatin	Simvastatin	140	44
Montelukast Sodium	Montelukast Sodium	130	39
Metoprolol Tartrate	Metoprolol Tartrate	119	37
Pioglitazone Hcl	Pioglitazone Hcl	116	39
Clopidogrel	Clopidogrel Bisulfate	111	40
Alprazolam	Alprazolam	106	23
Albuterol Sulfate Hfa	Albuterol Sulfate	101	28
Furosemide	Furosemide	98	38
Famotidine	Famotidine	96	29
Januvia	Sitagliptin Phosphate	84	24
Escitalopram Oxalate	Escitalopram Oxalate	83	22
Tramadol Hcl	Tramadol Hcl	83	25
Tradjenta	Linagliptin	81	17
Memantine Hcl	Memantine Hcl	79	28
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	75	71
Olmesartan Medoxomil	Olmesartan Medoxomil	75	25
Eliquis	Apixaban	72	18
Prednisone	Prednisone	72	60
Pregabalin	Pregabalin	69	20
Linzess	Linaclotide	68	22
Ezetimibe	Ezetimibe	58	20
Lactulose	Lactulose	58	12
Jardiance	Empagliflozin	57	19
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	54	18
Diclofenac Sodium	Diclofenac Sodium	53	24
Ozempic	Semaglutide	52	14
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	51	15
Meclizine Hcl	Meclizine Hcl	51	20
Mirtazapine	Mirtazapine	51	15
Allopurinol	Allopurinol	49	15
Sertraline Hcl	Sertraline Hcl	46	16
Trazodone Hcl	Trazodone Hcl	46	15
Trulicity	Dulaglutide	46	11
Valsartan	Valsartan	46	14
Alendronate Sodium	Alendronate Sodium	44	16
Isosorbide Mononitrate Er	Isosorbide Mononitrate	42	14
Finasteride	Finasteride	41	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	41	12
Acetaminophen-Codeine	Acetaminophen With Codeine	40	15
Azithromycin	Azithromycin	39	35
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	38	21
Lorazepam	Lorazepam	38	12
Cefdinir	Cefdinir	37	32
Glimepiride	Glimepiride	33	suppressed
Carvedilol	Carvedilol	32	13
Duloxetine Hcl	Duloxetine Hcl	32	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	32	suppressed
Clonazepam	Clonazepam	31	suppressed
Nifedipine Er	Nifedipine	31	suppressed
Buspirone Hcl	Buspirone Hcl	30	suppressed
Donepezil Hcl	Donepezil Hcl	30	12
Myrbetriq	Mirabegron	29	suppressed
Potassium Chloride	Potassium Chloride	29	13
Xarelto	Rivaroxaban	29	suppressed
Hydralazine Hcl	Hydralazine Hcl	28	12
Solifenacin Succinate	Solifenacin Succinate	28	suppressed
Dutasteride	Dutasteride	27	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	27	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	27	suppressed
Mounjaro	Tirzepatide	26	suppressed
Breo Ellipta	Fluticasone/Vilanterol	25	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	25	14
Dicyclomine Hcl	Dicyclomine Hcl	24	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Vascepa	Icosapent Ethyl	23	suppressed
Memantine Hcl Er	Memantine Hcl	21	suppressed
Nystatin	Nystatin	21	12
Colesevelam Hcl	Colesevelam Hcl	20	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	20	suppressed
Synthroid	Levothyroxine Sodium	20	suppressed
Farxiga	Dapagliflozin Propanediol	19	suppressed
Irbesartan	Irbesartan	19	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	19	suppressed
Levofloxacin	Levofloxacin	19	16
Naproxen	Naproxen	19	11
Rybelsus	Semaglutide	19	suppressed
Benazepril Hcl	Benazepril Hcl	18	suppressed
Clotrimazole	Clotrimazole	18	14
Dexlansoprazole Dr	Dexlansoprazole	18	suppressed
Hydrocortisone	Hydrocortisone	18	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	18	suppressed
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Constulose	Lactulose	17	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	17	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Ciclopirox	Ciclopirox	16	suppressed
Cilostazol	Cilostazol	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	12
Citalopram Hbr	Citalopram Hydrobromide	16	suppressed
Atenolol	Atenolol	15	suppressed
Glipizide	Glipizide	15	suppressed
Mupirocin	Mupirocin	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Tresiba Flextouch U-100	Insulin Degludec	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Celecoxib	Celecoxib	14	11
Ibuprofen	Ibuprofen	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Ciprofloxacin-Dexamethasone	Ciprofloxacin Hcl/Dexameth	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Lidocaine	Lidocaine	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	suppressed
Primidone	Primidone	12	suppressed
Spironolactone	Spironolactone	12	suppressed
Bupropion Xl	Bupropion Hcl	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Multaq	Dronedarone Hcl	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed
Xifaxan	Rifaximin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error